β¨ Medicines Consent and Tax Determination
NEW ZEALAND GAZETTE, No. 33
27 MARCH 2014
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Fentanyl Sandoz
Active Ingredient:
Fentanyl 2.1mg equivalent to 12.5mcg/hr
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Hexal AG, Holzkirchen, Germany
Product:
Fentanyl Sandoz
Active Ingredient:
Fentanyl 4.2mg equivalent to 25mcg/hr
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Hexal AG, Holzkirchen, Germany
Product:
Fentanyl Sandoz
Active Ingredient:
Fentanyl 6.3mg equivalent to 37.5mcg/hr
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Hexal AG, Holzkirchen, Germany
Product:
Fentanyl Sandoz
Active Ingredient:
Fentanyl 8.4mg equivalent to 50mcg/hr
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Hexal AG, Holzkirchen, Germany
Product:
Fentanyl Sandoz
Active Ingredient:
Fentanyl 12.6mg equivalent to 75mcg/hr
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Hexal AG, Holzkirchen, Germany
Product:
Fentanyl Sandoz
Active Ingredient:
Fentanyl 16.8mg equivalent to 100mcg/hr
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Hexal AG, Holzkirchen, Germany
Dated this 21st day of March 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go1863
Inland Revenue
Tax Administration Act 1994
Notice of Determination Regarding the Use of Fair Dividend Rate Method for a Type of Attributing Interest in a Foreign Investment Fund
-
This is a notice made under section 91AAO(5) of the Tax Administration Act 1994 of a determination made by the Commissioner of Inland Revenue under section 91AAO(1) of that Act.
-
Determination FDR 2014/02 was made on 11 March 2014 allowing certain portfolio investment entity funds managed by New Zealand Funds Management Limited to use the fair dividend rate method to calculate foreign investment fund income from Civic Capital Currency Offshore Fund Limited for the 2014 and subsequent income years.
-
The determination will appear in Inland Revenueβs Tax Information Bulletin, Vol. 26, No. 4, of May 2014 and will also be available on the Inland Revenue website at
www.ird.govt.nz
JOHN TREZISE, Investigations Manager, Investigations and Advice, Inland Revenue.
go1934
Justice
Anti-Money Laundering and Countering Financing of Terrorism Act 2009
Ministerial Exemptions Under the Anti-Money Laundering and Countering Financing of Terrorism Act 2009
In accordance with section 157(6)(b) of the Anti-Money Laundering and Countering Financing of Terrorism Act
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare21 March 2014
Medicines, Distribution Consent, Fentanyl Sandoz, Transdermal patch, Novartis New Zealand Limited
- STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health
π° Notice of Determination Regarding the Use of Fair Dividend Rate Method for a Type of Attributing Interest in a Foreign Investment Fund
π° Finance & RevenueTax Determination, Fair Dividend Rate Method, Foreign Investment Fund, New Zealand Funds Management Limited, Civic Capital Currency Offshore Fund Limited
- JOHN TREZISE, Investigations Manager, Investigations and Advice, Inland Revenue
βοΈ Ministerial Exemptions Under the Anti-Money Laundering and Countering Financing of Terrorism Act 2009
βοΈ Justice & Law EnforcementAnti-Money Laundering, Countering Financing of Terrorism, Ministerial Exemptions
NZ Gazette 2014, No 33